These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
These kits are intended for in vitro diagnostic use.
These kits are for research use only and are not intended to be used for diagnostic procedures.
Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
Biological risk products.
Storage between 2 and 8 ° C.
Reactive in liquid form.
Reactive in lyophilized form.
Reactive in frozen form.
Stability after opening at 2-8 ° C.
Products that can be refrozen.
Stability 12 months after refreezing at -20 ° C.
Additional control plasma for the TGT.
Additional control plasma for the Thrombin Generation Test (TGT) assay.
5 x 1.0 mL
The Safety Data Sheets and Notices are accessible to our registered customers.
Thrombin Generation Time (TGT) is an overall hemostasis test that measures the time and amount of thrombin generated in platelet-rich or platelet-poor plasma.
This test covers 4 important parameters which makes it possible to estimate the potential of an individual to generate thrombin and can individualize hyper or hypo-coagulable phenotypes. This test is also used to monitor conventional treatments for hemophilia and when using bypass therapy which is necessary when inhibitors develop in patients.
Lyophilized normal human plasma with decreased thrombin generation.